Stereotactic body radiotherapy in the management of painful bone metastases

Pavan Jhaveri, Bin S. Teh, Charles Bloch, Robert Amato, Edward Brian Butler, Arnold C. Paulino

Research output: Contribution to journalReview articlepeer-review

20 Scopus citations


More than 100,000 new cases of bone metastases are diagnosed each year, and they present an important clinical problem. They cause significant morbidity and quality-of-life issues in cancer patients. Conventional external-beam radiotherapy is currently the most common method to treat these metastases, with several randomized controlled trials showing no difference in effectiveness between multiple- and single-dosing treatment regimens. A newer technology to treat bone metastases is stereotactic body radiotherapy (SBRT), a radiation delivery method that allows for a large ablative dose to be accurately given to the target over one to a few fractions. This review details the role of SBRT in painful bone metastases, primarily in the vertebral column, but in other bony sites as well, its unique advantages and disadvantages, and its role in the treatment of tumors traditionally deemed radioresistant. Toxicity to surrounding normal tissues and patterns of local failures are also addressed.

Original languageEnglish (US)
Pages (from-to)782-788
Number of pages7
Issue number7
StatePublished - Jun 2008

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Stereotactic body radiotherapy in the management of painful bone metastases'. Together they form a unique fingerprint.

Cite this